Is it time to include [¹⁸F]FDG-PET/CT in the diagnostic work-up for lymph node staging in cN0 vulvar cancer patients?

Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3043-3045. doi: 10.1007/s00259-021-05317-z.

Authors

Nicolas Aide^{1

2}, Stephanie Markovina³, Annamaria Ferrero⁴

Affiliations

¹ Nuclear Medicine Department, University Hospital, Caen, France. aide-n@chu-caen.fr.
² INSERM ANTICIPE, Normandy University, Caen, France. aide-n@chu-caen.fr.
³ Department of Radiation Oncology and Siteman Cancer Center, Washington University in Saint Louis, St. Louis, MO, USA.
⁴ Academic Division Gynaecology and Obstetrics, Mauriziano Hospital, University of Torino, Torino, Italy.

PMID: 33768280
DOI: 10.1007/s00259-021-05317-z

No abstract available

Publication types

Editorial
Comment

MeSH terms

Female
Fluorodeoxyglucose F18*
Humans
Lymph Nodes / diagnostic imaging
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Vulvar Neoplasms* / diagnostic imaging

Substances

Fluorodeoxyglucose F18